The disease-modifying therapy is approved to treat all indications covered by Tysabri
News
FDA grants ODD to Nexcella’s multiple myeloma treatment
The drug is currently being assessed in a phase 1b/2a clinical trial
AstraZeneca’s Soliris approved in Japan for paediatric gMG patients
The drug is the first to be approved in Japan to treat children and adolescents with generalised myasthenia gravis
Pfizer’s maternal RSV vaccine receives FDA approval
The decision allows Abrysvo to be given to those who are 32 to 36 weeks into their pregnancy
GSK shares promising results from shingles vaccine trial
The varicella zoster virus that causes shingles and chicken pox is typically present in over 90% of adults globally
Research shows new technique could cut time to detect polio in half
This is the first time that this type of scientific method has been used to detect polio
NICE recommends Amryt’s Filsuvez for rare skin disorder
Around 670 people in England with epidermolysis bullosa will benefit from the treatment
Alligator Bioscience gains orphan designation for mitazalimab
Mitazalimab is a monoclonal antibody that has been created to sensitize tumours to chemotherapy
LEO receives marketing authorisation application for delgocitinib
The treatment is indicated for adults with moderate-to-severe chronic hand eczema
Men with enlarged prostates offered robotic treatment by fourth University Hospital
Aquablation is a robotic method that uses a high-pressure saline solution to remove tissue
EIP Pharma merges with CervoMed
The amalgamated company will focus on advancing neflamapimod for the treatment of dementia
NICE gives green light for MSD’s Keytruda
The decision is the first verdict based on data from a wider immunotherapy ‘basket’ study
Elfabrio receives vital MHRA authorisation
The therapy involves long-term enzyme replacement therapy for aduls with Fabry disease
NIH and Exothera in partnership to produce COVID-19 vaccine
The new vaccine is an alternative to injected versions and no medical training is needed to deliver it
Chiesi forms tech partnership with Aliada
The collaboration will focus on multiple enzyme cargoes modified using Aliada’s modular delivery platform
